Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-024
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Obtaining Domestic Production Drug Registration Certificate for Betahistine Mesilate Tablets
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or material omissions.
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") recently received the "Drug Registration Certificate" (Certificate No.: 2026S01523) issued by the National Medical Products Administration for Betahistine Mesilate Tablets, and the Company's Betahistine Mesilate Tablets have been approved for registration. The relevant situation is announced as follows:
I. Basic Information of the Drug